Maternal Uterine Vascular Origins of Fetal Alcohol Spectrum Disorders
胎儿酒精谱系疾病的母体子宫血管起源
基本信息
- 批准号:8040970
- 负责人:
- 金额:$ 13.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAKT Signaling PathwayAddressAffectAgonistAlcohol consumptionAlcohol-Induced DisordersAlcoholismAlcoholsArteriesAwardBehavior TherapyBiologicalBiological MarkersBiological ModelsBirdsBloodBlood CirculationBlood VesselsBlood flowCalciumCardiovascular systemCaveolaeCell Culture TechniquesCentrifugationChronicConfocal MicroscopyConsultDataDevelopmentEarly identificationEndothelial CellsEndotheliumEnvironmentEnzymesErythrocytesFetal Alcohol Spectrum DisorderFetal DevelopmentFetusFutureGene ExpressionGene ProteinsGoalsGrantGrowthHome environmentImageImmunoblottingIn VitroIndividualKnowledgeLabelLeadLipidsMAPK3 geneMass Spectrum AnalysisMeasurementMediatingMembrane MicrodomainsMentorshipModalityMothersNational Institute on Alcohol Abuse and AlcoholismNitric OxideNutritionalPathogenesisPathway interactionsPeer ReviewPhasePhosphorylationPhosphorylation SitePhysiologicalPlacentaPlayPositioning AttributePost-Translational Protein ProcessingPregnancyPregnant UterusPregnant WomenPreventionProcessProductionProtein ArrayProteinsProteomicsProto-Oncogene Proteins c-aktPublishingPulsatile FlowReportingResearchResearch PersonnelRoleScaffolding ProteinSet proteinSignal PathwaySignal TransductionSiteSocietiesSpecificityStrategic PlanningTechniquesTestingThird Pregnancy TrimesterTimeTrainingTranslatingTreatment EfficacyUterusVascular remodelingWestern BlottingWomanabstractingalcohol abuse therapyalcohol effectalcohol exposurealcohol measurementbasecaveolin 1cell typecostdesigndrinkingenzyme activityfetalhigh throughput technologyhuman NOS3 proteinin vivonovelpregnantpreventprotein expressionprotein profilingpublic health relevanceresponseshear stress
项目摘要
DESCRIPTION (provided by applicant): Efforts to successfully prevent or ameliorate the teratogenic effects of alcohol have been impeded, at least in part, by a limited understanding of the mechanisms by which alcohol damages the developing fetus. In this K99/R00 grant, we will explore the maternal uterine origins of Fetal Alcohol Spectrum Disorders (FASD) and devise a strategy for development of a future proteomic biomarker(s)/unique signature profile for maternal alcohol consumption. Coordinated growth and remodeling of the entire uterine circulation and creation of a placenta are requisites for normal fetal development. These intricate processes are controlled by endothelial-derived nitric oxide (NO) and enzyme activity of endothelial nitric oxide synthase (eNOS). The overall goal of this application is to investigate the direct effects of chronic binge alcohol on: 1) NO and eNOS-related signaling cascades in the uterine artery endothelium during pregnancy; and 2) the caveolae, the natural home for eNOS, and to utilize this knowledge to develop a high throughput proteomic biomarker(s)/unique signature profile for maternal alcohol consumption, a stated goal of NIAAA strategic plan for years 2009-2014. Unique pathways regulate NO and eNOS in the pregnant uterus and these play a distinct role in pregnancy-associated maternal uterine vascular adaptations. In specific aim#1, we will directly compare binge alcohol mediated adaptive responses and specific signaling pathways in the pregnant uterine artery endothelial cells under shear stress via graded pulsatile in vivo-like flow conditions. Data derived from these studies will provide the first mechanistic framework for understanding the interactions between shear stress and alcohol to regulate NO production in pregnant uterine endothelium. Binge alcohol alters the stoichiometric relationship between eNOS and cav-1 and with every bout of alcohol, there are significant rises in [Ca+2]i and in turn eNOS is driven away from the caveolae, its "natural home" which acts as a major stabilizing environment. In specific aim #2, we will investigate alcohol-induced repeated intracellular increases in [Ca+2]i and its effects on repeated depletion of eNOS from caveolae and NO production. In specific aim #3, we will utilize high throughput proteomics to identify a biomarker(s)/unique caveolar signature protein profile that is dependent on the level of alcohol insult. These findings will place us in an excellent position to understand the multimechanistic causes of alcohol damage, especially from the perspective of the mother and the uterus, and to correctly design and propose a comprehensive preventative strategy.
PUBLIC HEALTH RELEVANCE: Each year, at least 40,000 babies are born with FASD in the U.S. at an estimated cost of $1.4 million per individual and total cost of at least $6 billion. Efforts to successfully prevent or ameliorate the teratogenic effects of alcohol have been impeded, at least in part, by a limited understanding of the mechanisms by which alcohol damages the developing fetus. In this K99/R00 grant, we will explore the maternal uterine origins of Fetal Alcohol Spectrum Disorders (FASD) and devise a strategy for development a high throughput proteomic biomarker(s)/unique signature profile for maternal alcohol consumption.
描述(由申请人提供):由于对酒精损害发育中胎儿的机制了解有限,至少部分地阻碍了成功预防或改善酒精致畸作用的努力。在这笔 K99/R00 拨款中,我们将探索胎儿酒精谱系障碍 (FASD) 的母体子宫起源,并制定一项开发未来蛋白质组生物标志物/母体饮酒独特特征谱的策略。整个子宫循环的协调生长和重塑以及胎盘的形成是胎儿正常发育的必要条件。这些复杂的过程由内皮源性一氧化氮 (NO) 和内皮一氧化氮合酶 (eNOS) 的酶活性控制。该应用的总体目标是研究长期酗酒对以下方面的直接影响: 1) 妊娠期间子宫动脉内皮细胞中 NO 和 eNOS 相关信号级联; 2) 小窝(eNOS 的天然家园),并利用这些知识开发高通量蛋白质组生物标志物/孕产妇饮酒的独特特征谱,这是 NIAAA 2009-2014 年战略计划的既定目标。独特的途径调节妊娠子宫中的 NO 和 eNOS,这些途径在妊娠相关的母体子宫血管适应中发挥着独特的作用。在具体目标#1中,我们将通过分级脉动体内样流动条件直接比较剪切应力下怀孕子宫动脉内皮细胞中酗酒介导的适应性反应和特定信号通路。从这些研究中获得的数据将为理解剪切应力和酒精之间的相互作用来调节妊娠子宫内皮细胞一氧化氮的产生提供第一个机制框架。暴饮暴食会改变 eNOS 和 cav-1 之间的化学计量关系,每次饮酒后,[Ca+2]i 都会显着升高,进而 eNOS 会远离小凹,它的“天然家园”充当着主要稳定环境。在具体目标 2 中,我们将研究酒精诱导的细胞内 [Ca+2]i 反复增加及其对小凹中 eNOS 反复消耗和 NO 产生的影响。在具体目标#3中,我们将利用高通量蛋白质组学来识别依赖于酒精损伤水平的生物标志物/独特的小凹特征蛋白谱。这些发现将使我们能够很好地理解酒精损伤的多机制原因,特别是从母亲和子宫的角度,并正确设计和提出全面的预防策略。
公共卫生相关性:在美国,每年至少有 40,000 名婴儿出生时患有 FASD,估计每人花费 140 万美元,总花费至少 60 亿美元。由于对酒精损害发育中胎儿的机制了解有限,成功预防或改善酒精致畸作用的努力至少部分受到阻碍。在这笔 K99/R00 拨款中,我们将探索胎儿酒精谱系障碍 (FASD) 的母体子宫起源,并制定一项策略来开发母体饮酒的高通量蛋白质组生物标志物/独特的特征谱。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chronic binge alcohol exposure during pregnancy impairs rat maternal uterine vascular function.
- DOI:10.1111/acer.12431
- 发表时间:2014-07
- 期刊:
- 影响因子:0
- 作者:Subramanian K;Naik VD;Sathishkumar K;Yallampalli C;Saade GR;Hankins GD;Ramadoss J
- 通讯作者:Ramadoss J
Interactive effects of in vitro binge-like alcohol and ATP on umbilical endothelial nitric oxide synthase post-translational modifications and redox modulation.
- DOI:10.1016/j.reprotox.2013.11.006
- 发表时间:2014-01
- 期刊:
- 影响因子:0
- 作者:Subramanian K;Naik VD;Sathishkumar K;Sawant OB;Washburn SE;Wu G;Yallampalli C;Saade GR;Hankins GD;Ramadoss J
- 通讯作者:Ramadoss J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jayanth Ramadoss其他文献
Jayanth Ramadoss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jayanth Ramadoss', 18)}}的其他基金
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY.
电子烟
- 批准号:
10540752 - 财政年份:2021
- 资助金额:
$ 13.47万 - 项目类别:
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY.
电子烟
- 批准号:
10459954 - 财政年份:2021
- 资助金额:
$ 13.47万 - 项目类别:
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY.
电子烟
- 批准号:
10324577 - 财政年份:2021
- 资助金额:
$ 13.47万 - 项目类别:
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY
电子烟
- 批准号:
10116886 - 财政年份:2021
- 资助金额:
$ 13.47万 - 项目类别:
A Novel Platform for Maternal Alcohol Consumption Screening
孕产妇酒精摄入量筛查的新平台
- 批准号:
8822061 - 财政年份:2015
- 资助金额:
$ 13.47万 - 项目类别:
A Novel Mechanistic Framework for FASD Etiology.
FASD 病因学的新机制框架。
- 批准号:
10598031 - 财政年份:2015
- 资助金额:
$ 13.47万 - 项目类别:
Alcohol and Maternal Uterine Vascular Adaptations in Pregnancy
妊娠期酒精与母体子宫血管适应
- 批准号:
9053392 - 财政年份:2015
- 资助金额:
$ 13.47万 - 项目类别:
A Novel Mechanistic Framework for FASD Etiology.
FASD 病因学的新机制框架。
- 批准号:
10377467 - 财政年份:2015
- 资助金额:
$ 13.47万 - 项目类别:
A Novel Mechanistic Framework for FASD Etiology.
FASD 病因学的新机制框架。
- 批准号:
10459965 - 财政年份:2015
- 资助金额:
$ 13.47万 - 项目类别:
A Novel Platform for Maternal Alcohol Consumption Screening
孕产妇酒精摄入量筛查的新平台
- 批准号:
9136036 - 财政年份:2015
- 资助金额:
$ 13.47万 - 项目类别:
相似国自然基金
牛磺酸通过调节NGF-Akt/Bad信号通路对大鼠孕期砷暴露诱导子代孤独症样行为的作用研究
- 批准号:82360279
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
E3泛素连接酶NEDD4L负调控AKT/mTOR信号通路抑制结直肠癌肝转移的机制研究
- 批准号:82303416
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
解毒通络生津法通过调控PI3K-AKT信号通路促进原发性干燥综合征Treg细胞稳定的机制研究
- 批准号:82374318
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于“阳虚阴结”理论探讨甘草干姜汤通过Sirt1调控PI3K/Akt信号通路抑制肺成纤维细胞增殖干预RA-ILD的机制研究
- 批准号:82305166
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
电针调控外泌体circRNAs介导PI3K/Akt/mTOR信号通路调节功能性消化不良ICCs细胞自噬促胃肠动力的作用机制
- 批准号:82374598
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
- 批准号:
10476196 - 财政年份:2021
- 资助金额:
$ 13.47万 - 项目类别:
Ac-SDKP in the Treatment of Cardiac Dysfunction in Hypertension or Ischemic
Ac-SDKP 治疗高血压或缺血性心脏功能障碍
- 批准号:
10336561 - 财政年份:2021
- 资助金额:
$ 13.47万 - 项目类别:
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
雪旺细胞肿瘤中受体酪氨酸激酶层次结构的治疗靶向
- 批准号:
10249969 - 财政年份:2020
- 资助金额:
$ 13.47万 - 项目类别:
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
雪旺细胞肿瘤中受体酪氨酸激酶层次结构的治疗靶向
- 批准号:
10436971 - 财政年份:2020
- 资助金额:
$ 13.47万 - 项目类别:
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms - Supplement for Diversity
雪旺细胞肿瘤中受体酪氨酸激酶层次结构的治疗靶向 - 多样性补充
- 批准号:
10527086 - 财政年份:2020
- 资助金额:
$ 13.47万 - 项目类别: